amphotericin-b and Cyanosis

amphotericin-b has been researched along with Cyanosis* in 2 studies

Other Studies

2 other study(ies) available for amphotericin-b and Cyanosis

Article	Year
Acrocyanosis developed with amphotericin B deoxycholate but not with amphotericin B lipid complex. Mycoses, 2007, Volume: 50, Issue:3 Topics: Amphotericin B; Antifungal Agents; Cyanosis; Deoxycholic Acid; Drug Combinations; Fingers; Hand; Humans; Male; Middle Aged; Mucormycosis; Phosphatidylcholines; Phosphatidylglycerols	2007
Cyanotic Raynaud's phenomenon with conventional but not with liposomal amphotericin B: three case reports. Mycoses, 1997, Volume: 40, Issue:9-10 Despite its common adverse effects intravenous (i.v.) amphotericin B is an indispensable antifungal drug in childhood oncology. We report here on three cases of painful cyanotic Raynaud's phenomenon after i.v. administration or inhalation of amphotericin B. A liposomal i.v. preparation of amphotericin B was well tolerated by the infants. Spasms of peripheral vessels mediated by thromboxane A2 could be responsible for the Raynaud's phenomenon. Hence, inhibitors of prostaglandin synthesis are suggested for therapy. Topics: Administration, Inhalation; Adolescent; Amphotericin B; Antifungal Agents; Child; Cyanosis; Female; Humans; Injections, Intravenous; Leukemia, Myeloid; Leukemia, Myelomonocytic, Chronic; Liposomes; Lymphoma, Large-Cell, Anaplastic; Male; Raynaud Disease	1997

Article

Year

Acrocyanosis developed with amphotericin B deoxycholate but not with amphotericin B lipid complex.

Mycoses, 2007, Volume: 50, Issue:3

Topics: Amphotericin B; Antifungal Agents; Cyanosis; Deoxycholic Acid; Drug Combinations; Fingers; Hand; Humans; Male; Middle Aged; Mucormycosis; Phosphatidylcholines; Phosphatidylglycerols

2007

Cyanotic Raynaud's phenomenon with conventional but not with liposomal amphotericin B: three case reports.

Mycoses, 1997, Volume: 40, Issue:9-10

Despite its common adverse effects intravenous (i.v.) amphotericin B is an indispensable antifungal drug in childhood oncology. We report here on three cases of painful cyanotic Raynaud's phenomenon after i.v. administration or inhalation of amphotericin B. A liposomal i.v. preparation of amphotericin B was well tolerated by the infants. Spasms of peripheral vessels mediated by thromboxane A2 could be responsible for the Raynaud's phenomenon. Hence, inhibitors of prostaglandin synthesis are suggested for therapy.

Topics: Administration, Inhalation; Adolescent; Amphotericin B; Antifungal Agents; Child; Cyanosis; Female; Humans; Injections, Intravenous; Leukemia, Myeloid; Leukemia, Myelomonocytic, Chronic; Liposomes; Lymphoma, Large-Cell, Anaplastic; Male; Raynaud Disease

1997